6.2 Acute Ischaemic Stroke, Thrombolysis/Thrombectomy, TIA, and Intracranial Haemorrhage
Key Takeaways
Activate the stroke pathway for a new persisting focal deficit. Record last known well, check glucose and obtain urgent brain imaging. A negative FAST or low NIHSS does not exclude stroke.
Within 4.5 hours, assess eligible patients for alteplase or tenecteplase under the local stroke protocol. Selected late or wake-up presentations require specialist imaging-based selection.
Arrange thrombectomy urgently for an eligible large-vessel occlusion, including selected later and basilar presentations. Start indicated IV thrombolysis without delaying transfer or thrombectomy.
Suspected TIA, including transient retinal ischaemia, needs urgent specialist assessment within 24 hours and immediate aspirin 300 mg when appropriate. Persistent retinal or cerebral deficits activate the emergency pathway.
Reverse relevant anticoagulation urgently in spontaneous ICH and individualise BP treatment by bleed severity. After a negative late CT with continuing suspicion of SAH, consider lumbar puncture at least 12 hours after onset.
Recognise acute stroke and activate the pathway
Stroke is acute neurological injury from infarction or haemorrhage. Brain, retinal or spinal infarction can be demonstrated even after symptoms resolve. Activate the stroke pathway for a sudden persisting focal deficit. Record the exact onset or last known well, including when a person went to sleep and first noticed symptoms. Stabilise airway, breathing and circulation, check capillary glucose and treat hypoglycaemia. Review anticoagulants, baseline function and other contraindications in parallel with imaging. A seizure, migraine aura or hypoglycaemia can mimic stroke. New focal signs after a seizure can also occur with stroke.
FAST and the NIH Stroke Scale
FAST looks for new facial asymmetry, arm weakness and speech change, with the time element prompting an emergency response. Sudden field loss, diplopia, dysarthria, ataxia or an acute vestibular syndrome can signal posterior circulation stroke even when FAST is negative. Persistent new monocular visual loss may be retinal stroke and warrants emergency stroke and ophthalmology assessment.
The NIH Stroke Scale (NIHSS, 0–42) records consciousness, eye movements, fields, facial and limb motor function, ataxia, sensation, language, dysarthria and neglect. Use it to document the deficit and follow change. A low score can still accompany a disabling deficit, particularly with posterior circulation stroke. Vascular imaging establishes whether a large artery is occluded.
HSE stroke symptoms · UK and Ireland acute stroke guideline · Tissue-based definition of stroke · NIHSS in posterior stroke cohort
Localise the deficit at the bedside
| Territory | Findings that support localisation |
|---|---|
| Anterior cerebral artery | Contralateral leg weakness and sensory loss greater than in the arm. Medial frontal involvement may cause abulia. |
| Middle cerebral artery | Contralateral face and arm weakness or sensory loss, often with a homonymous field deficit. Dominant hemisphere involvement can cause aphasia, and non-dominant involvement can cause neglect. A large hemispheric lesion can cause gaze preference towards the affected hemisphere. |
| Posterior cerebral artery | Contralateral homonymous field loss, sometimes with macular sparing. Dominant occipital and splenial injury can cause alexia without agraphia. Thalamic involvement may cause sensory symptoms. |
| Lateral medulla | Vertebral or PICA territory injury may cause ipsilateral Horner syndrome, facial sensory loss and ataxia with contralateral body pain and temperature loss. Dysphagia, hoarseness and vertigo are important clues. |
| Ventral pons | Basilar occlusion can cause bilateral weakness and impaired bulbar function. Extensive ventral pontine infarction can cause locked-in syndrome with quadriplegia, anarthria and preserved awareness and vertical eye movements. |
Worked localisation
A patient develops aphasia, right facial and arm weakness and leftward gaze preference. These signs localise to the dominant left hemisphere and raise suspicion of a proximal left MCA occlusion. Document last known well and confirm the vessel with angiography. A different patient with new dysphagia, vertigo and crossed sensory signs may have a posterior circulation stroke even with a low NIHSS. Both need rapid specialist assessment.
UK and Ireland stroke guideline on recognition and imaging · Lateral medullary infarct cohort · Vascular territory stroke registry · ESO/ESMINT basilar artery occlusion guideline
Choose imaging and reperfusion without delay
- Brain imaging. In the usual emergency pathway, obtain immediate non-contrast CT to identify haemorrhage and assess early ischaemic changes. Loss of grey-white differentiation, sulcal effacement or a hyperdense artery can support an ischaemic diagnosis. Early CT can appear normal. The UK and Ireland guideline calls for brain imaging as soon as possible and within one hour of arrival.
- Vascular imaging. If thrombectomy may be indicated, obtain CT angiography promptly to identify the occlusion and relevant cervical vascular disease. Avoid delaying indicated IV thrombolysis while obtaining additional imaging. Use CT or MR perfusion, or selected MRI diffusion–FLAIR findings, for extended-window decisions according to the stroke pathway. Perfusion software estimates core and hypoperfusion. Interpret these estimates with the scan, time course and clinical findings.
- IV thrombolysis. The UK and Ireland guideline considers alteplase or tenecteplase for eligible patients within 4.5 hours of known onset. Confirm the agent, dose, timing and eligibility under the local stroke protocol and current product information. Review imaging, BP, anticoagulant exposure and relevant tests, recent bleeding, surgery, head trauma and other contraindications. A standard coagulation panel alone may not exclude clinically relevant DOAC effect. The UK and Ireland guideline advises against routine reversal of a DOAC to enable thrombolysis. Any selected exception requires specialist adjudication under the applicable protocol.
- Extended-window IV treatment. A stroke specialist may consider alteplase beyond 4.5 hours in selected patients with salvageable tissue on perfusion imaging or an appropriate diffusion–FLAIR mismatch. The UK and Ireland guideline includes selected 4.5–9-hour and wake-up presentations. These specialist criteria extend beyond the routine early treatment window in the Irish alteplase label.
- Endovascular thrombectomy. Discuss an eligible disabling large-vessel occlusion urgently with the thrombectomy centre. A proximal anterior circulation occlusion can be treated within six hours, and selected cases can benefit up to 24 hours from last known well. Selection considers the vessel, imaging, time, deficit and prior function. Selected patients with a larger predicted core can benefit. Selected patients with moderate-to-severe basilar occlusion can also benefit within 24 hours. Start indicated IV thrombolysis promptly while arranging thrombectomy. Do not wait for a response before proceeding.
- Monitor and start prevention. ESO recommends BP below 185/110 mmHg before IV thrombolysis and below 180/105 mmHg during and for 24 hours after reperfusion. Avoid actively targeting SBP below 140 mmHg in the first 24 hours after successful thrombectomy. If reperfusion is not planned, avoid routine early lowering unless another indication or very high BP warrants specialist-directed treatment. After IV thrombolysis, wait 24 hours and exclude significant haemorrhage on follow-up imaging before starting antiplatelet therapy. Complete a swallow screen before oral food, fluids or medication.
| IV agent | Adult ischaemic stroke dose |
|---|---|
| Alteplase | Irish Actilyse label: 0.9 mg/kg, maximum 90 mg. Give 10% as the initial IV bolus and infuse the remainder over 60 minutes. |
| Tenecteplase | ESO guidance uses 0.25 mg/kg. The EU Metalyse 25 mg stroke product label specifies weight bands and a single IV bolus over about 5–10 seconds, with maximum 25 mg. Apply the locally approved stroke regimen and check the actual preparation. The myocardial infarction dose is different. |
Worked dosing example. At 80 kg, the Actilyse dose is 72 mg total, with a 7.2 mg bolus and 64.8 mg infusion. If the local pathway instead uses the EU Metalyse label bands, 80 kg is in the 80 to less than 90 kg band and the dose is 22.5 mg. The two regimens use different agents, preparations and schedules.
UK and Ireland acute stroke guideline · ESO acute stroke BP guideline · ESO tenecteplase recommendation · HPRA Actilyse product information · EMA Metalyse product information
Transient ischaemic attack and early secondary prevention
Transient ischaemic attack (TIA) is transient focal neurological dysfunction from brain, spinal cord or retinal ischaemia without acute infarction. At initial assessment, use the history and current symptoms to act promptly. A persistent focal deficit activates the emergency stroke pathway. Symptoms may resolve even when subsequent imaging shows infarction.
Transient monocular visual loss
A sudden painless grey-out or blackout in one eye that clears within minutes may be retinal ischaemia. Ipsilateral carotid disease or a cardiac embolic source may be responsible. Assess for giant cell arteritis in parallel with the stroke and eye pathways. A strong suspicion of arteritis with threatened vision requires immediate treatment and specialist assessment. A persistent visual deficit needs emergency stroke and ophthalmology assessment. A resolved suspected retinal TIA still requires urgent specialist evaluation.
Urgent assessment and prevention
The UK and Ireland stroke guideline recommends aspirin 300 mg immediately for suspected TIA unless contraindicated, and stroke specialist assessment within 24 hours. This initial TIA recommendation differs from antiplatelet timing in ongoing acute stroke. The ABCD2 score appeared in earlier studies and dual antiplatelet trials. It does not determine referral urgency or subsequent treatment decisions under this guideline.
- Antithrombotic treatment: After specialist assessment and appropriate brain imaging, eligible patients with non-cardioembolic TIA or minor ischaemic stroke presenting within 24 hours who have low bleeding risk may receive short-course dual antiplatelet therapy under the stroke pathway. One UK and Ireland regimen uses aspirin 300 mg and clopidogrel 300 mg as loading doses, followed by 75 mg daily of each for 21 days, then clopidogrel 75 mg daily alone. A cardioembolic source, haemorrhage or contraindications change the plan.
- Carotid disease: For a candidate for carotid intervention, obtain carotid imaging within 24 hours of specialist assessment. In eligible stable patients with symptomatic 50–99% stenosis measured by NASCET, refer promptly for endarterectomy to be performed as soon as possible and within seven days of symptom onset under the UK and Ireland guideline. Duplex ultrasound, CT angiography or MR angiography can assess the carotids. Continue optimal medical treatment.
- Risk factors and rhythm: Address smoking, blood pressure, diabetes and lipids. The UK and Ireland secondary prevention guideline recommends initial rhythm monitoring for at least 24 hours when AF or flutter is not known and anticoagulation would be appropriate. Consider longer monitoring for suspected cardioembolism. Start appropriate lipid-lowering therapy. For stroke or TIA with atherosclerosis, this guideline uses an LDL cholesterol target below 1.8 mmol/L.
- Atrial fibrillation: When AF is identified, the stroke team assesses anticoagulation. After ischaemic stroke the timing depends on infarction, bleeding risk and imaging. OPTIMAS supports early initiation in selected patients, with timing decided in context.
Plan post-stroke rehabilitation and discharge
Assess communication, swallowing, mobility and transfers, upper-limb function, cognition, mood and daily activities once clinically appropriate. Agree realistic goals with the patient and relevant carers. Involve stroke nurses, physiotherapy, occupational therapy and speech and language therapy according to need. Review the home environment, ability to manage medicines and meals, transport and who will provide support. Communicate swallowing and other safety plans at each handover.
Under the UK and Ireland stroke guideline, a patient with mild to moderate disability who can return to a suitable home setting should be offered early supported discharge where an appropriate specialist service can provide the necessary rehabilitation and treatment at home. Arrange the handover before discharge and confirm when the team will begin. Patients who need inpatient specialist rehabilitation should be referred according to their deficits and goals. Arrange appropriate community follow-up for ongoing needs, and continue secondary prevention and education about recurrent stroke symptoms.
UK and Ireland stroke service organisation · HSE stroke recovery
Distinguish spontaneous intracerebral and subarachnoid haemorrhage
Spontaneous intracerebral haemorrhage
Hypertensive small-vessel disease can cause deep haemorrhage in the basal ganglia, thalamus, pons or cerebellum. Cerebral amyloid angiopathy is an important cause of lobar haemorrhage in older adults. Consider anticoagulants, a vascular lesion, venous thrombosis or a tumour when suggested by the presentation and imaging. Admit to a monitored specialist pathway and repeat imaging urgently if the patient deteriorates.
- Blood pressure. Monitor closely and use titratable IV treatment when indicated. In early minor or moderate spontaneous ICH with haematoma volume below 30 mL and elevated SBP, the 2025–26 ESO guidance supports early reduction below 140 mmHg to limit expansion. Avoid marked reductions and hypotension. Seek an individual target in large bleeds, very high presenting BP, suspected raised ICP or planned evacuation. The 2023 UK and Ireland pathway gives a 130–139 mmHg target within an hour for eligible patients presenting with SBP 150–220 mmHg and lists exceptions. Later ESO guidance adds specific caution for larger haematomas.
- Anticoagulant reversal. Stop the anticoagulant and reverse relevant exposure urgently with stroke and haematology input. For warfarin, give four-factor PCC plus IV vitamin K, commonly 10 mg in this setting. Choose the PCC dose by INR, weight, product and local protocol. Check INR after treatment. PCC is preferred to plasma for prompt reversal. For dabigatran, the EU idarucizumab dose is 5 g IV, supplied as two 2.5 g vials given consecutively. In life-threatening or uncontrolled bleeding on apixaban or rivaroxaban, the EU indication for andexanet applies. ESO/EANS considers it in selected recent exposures to reduce expansion, with uncertain functional benefit and increased thrombotic risk. The HSE prescribing protocol reserves andexanet in ICH for individual decisions with relevant experts. Use the local specialist pathway to select reversal. HSE andexanet protocol For relevant heparin exposure, assess protamine by heparin type, dose and timing. It only partly reverses LMWH activity.
- Neurosurgical assessment. Escalate for deteriorating consciousness, mass effect, hydrocephalus or a posterior fossa haemorrhage. External ventricular drainage may be needed for hydrocephalus contributing to impaired consciousness. Cerebellar evacuation depends on volume, compression, hydrocephalus and clinical course. ESO/EANS suggests evacuation above 15 mL to improve survival. Spontaneous haemorrhage thresholds do not govern evacuation of traumatic extra-axial collections.
Suspected aneurysmal subarachnoid haemorrhage
A thunderclap headache peaks within about a minute. Vomiting, neck stiffness, photophobia, a focal deficit or transient loss of consciousness can accompany it. Obtain urgent non-contrast CT. If a radiologist reports a normal scan obtained within six hours, NICE advises against routine lumbar puncture and recommends senior review for alternative diagnoses and specialist advice. If the scan is negative after six hours and suspicion persists, consider lumbar puncture when safe, at least 12 hours after onset, to test CSF for bilirubin by spectrophotometry. Interpret the sample with the laboratory. A fall in red cell count across collection tubes is insufficient to exclude SAH.
Once SAH is confirmed, seek urgent neurovascular advice and use CTA to identify the source, with specialist angiography if needed. Select coiling or clipping based on anatomy, condition and specialist assessment. The 2026 ESO/EANS/ESMINT consensus suggests securing the ruptured aneurysm within 24 hours when feasible with the expert team. Give early enteral nimodipine for confirmed aneurysmal SAH according to the specialist pathway. The Irish oral regimen uses 60 mg every four hours for a 21-day course when given orally from the outset. Monitor BP and maintain euvolaemia. New neurological deterioration after SAH needs urgent assessment for rebleeding, hydrocephalus or delayed cerebral ischaemia.
ESO/EANS intracerebral haemorrhage guideline · ESO acute stroke BP update · EMA Praxbind · EMA Ondexxya · NICE SAH diagnostic pathway · ESO/EANS/ESMINT aneurysmal SAH guideline · HPRA Nimotop tablets
A 66-year-old right-handed man is brought to the emergency department by ambulance 65 minutes after developing sudden-onset right facial droop, profound weakness of the right arm and leg, and complete inability to speak. On arrival, he is alert but exhibits dense global aphasia, conjugate eye deviation to the left, and flaccid right hemiplegia (baseline NIHSS score of 19). Vital signs are: blood pressure 166/92 mmHg, heart rate 76 beats/min, respiratory rate 16 breaths/min, and point-of-care blood glucose 5.8 mmol/L. Emergency non-contrast CT head shows no evidence of haemorrhage and an ASPECTS score of 10. CT angiography demonstrates a complete cut-off and occlusive thrombus in the proximal left middle cerebral artery (M1 segment). The patient's body weight is 80 kg. Laboratory blood tests confirm a platelet count of 220 x 10^9/L and an INR of 1.0. He was independent before this event and has no contraindication to IV thrombolysis. The local protocol uses alteplase. What is the most appropriate acute reperfusion strategy?
Administer oral aspirin 300 mg immediately, admit to the stroke unit, and perform elective carotid Doppler ultrasound in 48 hours
Initiate an intravenous labetalol infusion targeting a systolic blood pressure below 130 mmHg before considering reperfusion therapies
Transfer directly to the interventional neuroradiology suite for mechanical thrombectomy while withholding intravenous alteplase to minimize bleeding risk
Administer intravenous alteplase (7.2 mg bolus followed by 64.8 mg over 60 minutes) immediately, while simultaneously preparing the interventional team for emergent endovascular mechanical thrombectomy
A 74-year-old woman taking warfarin for non-valvular atrial fibrillation is brought to the emergency department after acute collapse. Her family witnessed sudden left-sided weakness, severe headache, and vomiting 2 hours ago. On arrival, she is somnolent with a GCS of 11 (E3, V3, M5), BP 196/108 mmHg, and HR 84 bpm irregular. Physical examination demonstrates dense left-sided flaccid hemiplegia and left hemineglect. An urgent non-contrast CT head demonstrates a 45 mL hyperdense haematoma in the right basal ganglia (putamen) with surrounding oedema and 4 mm midline shift, without intraventricular extension. Point-of-care laboratory testing reveals an INR of 3.4. What is the most appropriate immediate medical management for this patient?
Administer intravenous fresh frozen plasma (FFP) 15 mL/kg, withhold blood pressure treatment, and observe on a general medical ward
Give four-factor PCC and 10 mg IV vitamin K promptly. Begin monitored BP management with the stroke and neurocritical care teams and obtain urgent neurosurgical advice.
Administer intravenous idarucizumab 5 g bolus, initiate intravenous mannitol, and transfer urgently for decompressive suboccipital craniectomy
Administer intravenous andexanet alfa bolus, maintain systolic blood pressure between 180 and 200 mmHg to preserve cerebral perfusion pressure, and repeat CT in 24 hours
A 42-year-old woman presents to the emergency department complaining of an excruciating headache that started abruptly 14 hours ago while lifting heavy furniture at home. She describes it as reaching 10/10 severity in less than 30 seconds and states she has never felt such severe pain in her life. The headache is accompanied by photophobia, neck stiffness, and multiple episodes of vomiting. On examination, she is alert and oriented, afebrile, BP 138/82 mmHg, with marked resistance to passive neck flexion, but no focal cranial nerve or limb deficits. An urgent non-contrast CT head performed 14.5 hours after symptom onset is reviewed by a specialist radiologist and reported as completely normal with no intracranial haemorrhage identified. What is the most appropriate next step in the diagnostic and therapeutic management of this patient?
Reassure the patient that a normal CT head definitively excludes subarachnoid haemorrhage, prescribe oral sumatriptan for an acute migraine, and discharge home
Perform an immediate lumbar puncture to measure CSF opening pressure and analyze for oligoclonal bands, and initiate high-dose oral prednisolone
After senior review, perform lumbar puncture if safe and send CSF for bilirubin by spectrophotometry.
Perform an immediate digital subtraction cerebral angiogram under general anaesthesia without prior lumbar puncture, and initiate intravenous unfractionated heparin
Following a stroke, a patient is medically stable with mild to moderate disability. A home assessment confirms a suitable setting, and the specialist team can provide prompt rehabilitation at home. The patient prefers to return home. Which plan best supports recovery?
Arrange stroke early supported discharge with a named rehabilitation team, agreed goals and a coordinated handover
Discharge without follow-up once the acute causes have been treated
Wait until every impairment has resolved before starting rehabilitation
Use preventive medication as the only post-stroke intervention
Sections you finish are checked off in the contents.